• Actuate Therapeutics held its annual stockholder meeting on May 21, 2026.
• Stockholders elected Aaron G.L. Fletcher, Ph.D. and Jason Keyes to the board.
• Crowe LLP’s appointment as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026 was ratified.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actuate Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-004268), on May 22, 2026, and is solely responsible for the information contained therein.